◆ SpookStack

_ DAY 3: Alternate: Combine categories #7 and #8: Immu ig and Treatment Chairmen #7: Immunity and Vaccines . Co-Chairme nid B. Ivins AVA and rPA vaccine potency and safety: comparisons.in animals (Ivins of] Efficac gainst vaccine-refractory strains r Ivins) DNA vaccines (eg. . (and t al.) PA progucing recombinant B.anthracis vaccines LF-fusion aroteins Other experimental vaccines: (Live at i < Correlates of immune protection In vitro correlate/animal models USAMAIID. = Dena (ceo_____] Human immuné responses to anthrax vaccine {7 The SCID mouse model- #8: Prevertinn and Tieatmant {Oct4imen Vaccines and Treatments] Chairmen:| : Anthrax vaccination: Sie and immunogenicity of alternate schedules and routes: Suveliance oti persorinel immunized with AVA: : Human Clinical studies with PAVAX Human antitoxin antibod ("scFV": Los Alamos) Toxin competitive inhibitors